India’s pharma market dips to a 2-year low in May – Feedback

The Indian pharmaceuticals market’s growth this May has been the lowest in two years, impacted by a drop in sales of fixed dose combination drugs, fresh price cuts and a lower-than-expected uptake, according to pharmaceutical market research company AIOCD PharmaTrack.

For May, the pharmaceuticals market grew by 7.7% compared to 11.6% during the same month last year, reaching sales of Rs 99,476 crore over a 12-month period based on Moving Annual Total (MAT), according to an agency release. The country’s FDC market dropped 14.6% and is now valued at Rs 196 crore and anti-infectives, derma and respiratory were the worst-hit segments, it added. Fixed dose combination (FDC) drugs are products that have a combination of two or more therapeutic ingredients in a single dose. Indian drug makers were more affected by the drop in volumes in FDCs than multinational drug makers in the country, according to PharmaTrack.

http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indias-pharma-market-dips-to-a-2-year-low-in-may/articleshow/52683236.cms

About news

We take care of publishing the latest investment news and highlights for Feedback

Leave a Reply

Your email address will not be published. Required fields are marked *